Skip to main content

Peer Review reports

From: TENERGY: multicenter phase II study of Atezolizumab monotherapy following definitive Chemoradiotherapy with 5-FU plus Cisplatin in patients with unresectable locally advanced esophageal squamous cell carcinoma

Original Submission
10 Jan 2020 Submitted Original manuscript
29 Feb 2020 Author responded Author comments - Hideaki Bando
3 Mar 2020 Author responded Author comments - Hideaki Bando
Resubmission - Version 2
29 Feb 2020 Submitted Manuscript version 2
Publishing
5 Mar 2020 Editorially accepted
20 Apr 2020 Article published 10.1186/s12885-020-06716-5

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us